Lifetime risk of cardiovascular disease stratified by traditional risk factors: Findings from the cohort of Tehran lipid and glucose study

Background: We aimed to estimate the lifetime risk (LTR) of cardiovascular disease (CVD) in the Iranian population, stratified by sex and traditional risk factors including high body mass index (BMI), hypertension, diabetes, smoking, and hypercholesterolemia. Methods: We included 10222 (4430 men) pa...

Full description

Bibliographic Details
Published in:	Hellenic Journal of Cardiology
Main Authors:	Azra Ramezankhani, Fereidoun Azizi, Farzad Hadaegh
Format:	Article
Language:	English
Published:	Elsevier 2023-09-01
Subjects:	lifetime risk cardiovascular disease risk factors women men
Online Access:	http://www.sciencedirect.com/science/article/pii/S1109966623000349

Similar Items

Sex Differences in Cumulative Exposure to Metabolic Risk Factors Before Hypertension Onset: The Cohort of the Tehran Lipid and Glucose Study
by: Azra Ramezankhani, et al.
Published: (2021-12-01)

Incidence and associated risk factors for premature death in the Tehran Lipid and Glucose Study cohort, Iran
by: Ali Eslami, et al.
Published: (2019-06-01)

Association of Lipid Profile With Cardiovascular Diseases and All‐Cause Death: A 2‐Decade Follow‐Up of the Tehran Lipid and Glucose Study
by: Azra Ramezankhani, et al.
Published: (2025-08-01)

Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study
by: Azra Ramezankhani, et al.
Published: (2022-11-01)

Association of fasting glucose with lifetime risk of incident heart failure: the Lifetime Risk Pooling Project
by: Arjun Sinha, et al.
Published: (2021-03-01)

The relationship between glucose intolerance status and risk of hospitalization during two decades of follow-up: Tehran lipid and glucose study
by: Rahele Rasooli, et al.
Published: (2022-12-01)

The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study
by: Farzad Hadaegh, et al.
Published: (2021-01-01)

Age and aging effects on blood pressure: 15 years follow‐up of Tehran lipid and glucose study
by: Alireza Khajavi, et al.
Published: (2021-06-01)

Risk-stratified lifetime risk and incidence of hip fracture and falls in middle-aged and elderly Chinese population: The China health and retirement longitudinal study
by: Guangyuan Du, et al.
Published: (2025-01-01)

Genetic testing and risk interpretation: How do women understand lifetime risk results?
by: Yaniv Hanoch, et al.
Published: (2010-04-01)

Predictors of decline in kidney function in the general population: a decade of follow-up from the Tehran Lipid and Glucose Study
by: Soroush Masrouri, et al.
Published: (2023-12-01)

Sex differences in risk factors for coronary heart disease events: a prospective cohort study in Iran
by: Azra Ramezankhani, et al.
Published: (2023-12-01)

Googling the Lifetime Risk of Stroke Around the World
by: Thanh G. Phan, et al.
Published: (2020-07-01)

Different Metabolic Phenotypes of Obesity and 2 Decades Risk of Cardio–Renal–Metabolic Multimorbidity: Tehran Lipid and Glucose Study
by: Danial Molavizadeh, et al.
Published: (2025-09-01)

Gender differences in the impact of 3-year status changes of metabolic syndrome and its components on incident type 2 diabetes mellitus: a decade of follow-up in the Tehran Lipid and Glucose Study
by: Farzad Hadaegh, et al.
Published: (2023-05-01)

Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study
by: Azizi Fereidoun, et al.
Published: (2010-05-01)

Weight change and risk of incident type 2 diabetes: short, medium and long-term follow-up in tehran lipid and glucose study
by: Samaneh Asgari, et al.
Published: (2024-06-01)

The trend of 10-year cardiovascular risk among diabetic and non-diabetic participants in Tehran Lipid and glucose study: 1999–2018
by: Fatemeh Koohi, et al.
Published: (2022-03-01)

The difference between 2-hour post-challenge and fasting plasma glucose associates with the risk of cardiovascular disease in a normoglycemic population: the Tehran lipid and glucose study
by: Amir Abdi, et al.
Published: (2024-02-01)

The lifetime risk of developing type II diabetes in an urban community in Mumbai: findings from a ten-year retrospective cohort study
by: Palak Sharma, et al.
Published: (2023-08-01)

A 10-Year Cardiovascular Risk in Adults with Different Levels of Spiritual Health: Tehran Lipid and Glucose Study
by: Parisa Amiri, et al.
Published: (2023-01-01)

Incidence and lifetime risk of uterine corpus cancer in Taiwanese women from 1991 to 2010
by: Jerry Cheng-Yen Lai, et al.
Published: (2017-02-01)

An alternative approach for the excess lifetime cancer risk and prediction of radiological parameters
by: Uyanık Nurten Ayten
Published: (2023-09-01)

Effect of weight change on the association between overall and source of carbohydrate intake and risk of metabolic syndrome: Tehran lipid and glucose study
by: Somayeh Hosseinpour-Niazi, et al.
Published: (2023-09-01)

Association between estimated glomerular filtration rate slope and cardiovascular disease among individuals with and without diabetes: a prospective cohort study
by: Azra Ramezankhani, et al.
Published: (2023-10-01)

Modifiable Factors and 10‐Year and Lifetime Risk of Cardiovascular Disease in Adults With New‐Onset Diabetes: The Kailuan Cohort Study
by: Shouling Wu, et al.
Published: (2025-08-01)

Modifiable factors and 10-year and lifetime cardiovascular disease risk in adults with new-onset hypertension: insights from the Kailuan cohort
by: Shouling Wu, et al.
Published: (2025-02-01)

An Overview of Lifetime Management of Power Electronic Converters
by: Saeed Rahimpour, et al.
Published: (2022-01-01)

Lifetime risk of developing and dying from cancer in Henan Province, China: current status, temporal trends, and disparities
by: Qiong Chen, et al.
Published: (2025-04-01)

Differences in the impact of impaired glucose status on clinical outcomes in younger and older adults: Over a decade of follow-up in the Tehran lipid and glucose study
by: Samaneh Asgari, et al.
Published: (2022-10-01)

Sex specific incidence rates of type 2 diabetes and its risk factors over 9 years of follow-up: Tehran Lipid and Glucose Study.
by: Arash Derakhshan, et al.
Published: (2014-01-01)

Evaluation of Excess Lifetime Cancer Risk for Environmental Exposures in Kaduna, Nigeria
by: Gyuk P Musa, et al.
Published: (2025-09-01)

Modifiable lifestyle factors and lifetime risk of atrial fibrillation: longitudinal data from the Korea NHIS-HealS and UK Biobank cohorts
by: Hanjin Park, et al.
Published: (2024-05-01)

Anthropometric indices and the risk of incident sudden cardiac death among adults with and without diabetes: over 15 years of follow-up in The Tehran Lipid and Glucose Study
by: Seyyed Saeed Moazzeni, et al.
Published: (2021-07-01)

The association between index-year, average, and variability of the triglyceride-glucose index with health outcomes: more than a decade of follow-up in Tehran lipid and glucose study
by: Danial Molavizadeh, et al.
Published: (2024-08-01)

Ideal Cardiovascular Health Metric and Its Change With Lifetime Risk of Cardiovascular Diseases: A Prospective Cohort Study
by: Lulin Wang, et al.
Published: (2021-11-01)

Levels and Health Risk Assessment of Polycyclic Aromatic Hydrocarbons in Vegetable Oils and Frying Oils by Using the Margin of Exposure (MOE) and the Incremental Lifetime Cancer Risk (ILCR) Approach in China
by: Qing Liu, et al.
Published: (2023-02-01)

Estimation of Radiation Equivalent Dose and Lifetime Attributable Risk from Pediatric CAP CT Examination
by: Khalid M. Aloufi
Published: (2024-10-01)

Association between metabolic score for insulin resistance and clinical outcomes: insights from the Tehran lipid and glucose study
by: Seyyed Saeed Tamehri Zadeh, et al.
Published: (2024-06-01)

Ideal cardiovascular health status and risk of cardiovascular disease and all-cause mortality: over a decade of follow-up in the Tehran lipid and glucose study
by: Farzad Hadaegh, et al.
Published: (2022-08-01)